BLRX 주가 차트
BLRX 주가 예측
BioLineRx Ltd.
$3.1
-7.46%
$-0.25
종가: May 07, 16:00:00 GMT-4
$3.1
0%
$0
애프터마켓: May 07, 20:00:00 GMT-4
뒤로
BioLineRx Ltd. (BLRX) 주가 예측
주요 통계
이전 종가
$3.35
시가
$3.29
일일 범위
$3.1 - $3.33
52주 범위
$2.15 - $7.77
거래량
13.5K
평균 거래량
18.3K
배당수익률
--
EPS(TTM)
0.00
시가총액
$13.4M
BioLineRx Ltd.란 무엇인가요?
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
